Australian Scientists Identify Experimental Drug That Could Stop Neuroblastoma Cancer
- OPACC
- Nov 5, 2015
- 1 min read
Melbourne: Australian scientists have identified a critical molecular 'feedback loop' that helps initiate and drive neuroblastoma, a cancer of the nervous system in children that is triggered in embryonal nerve cells. The research team was able to identify an experimental drug, which was currently in clinical trials for adult cancer, with the potential to interrupt the loop and halt tumour progression, Australia-based Children's Cancer Institute said.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments